ReporterLens™ analysis of "AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes" — CNBC. Analyst archetype. Emotional tone 3/10. Attribution 6/10. Headline accuracy 8/10. Read the full ReporterLens™ breakdown of sourcing, evidence, and narrative framing.